AXTI
Why the market hit the brakes
AXT, Inc. is getting whacked after unveiling a proxy proposal to raise its authorized share count from 70 million to 120 million. That’s not a tiny tweak; it’s the kind of move that makes shareholders reach for the aspirin.
Why investors are nervous
The math is doing the scary part here. More authorized shares can mean more room for future equity issuance, and that can dilute existing holders if the company taps the market for cash. In plain English: your slice of the pie could get thinner.
The company’s pitch
AXT says the extra equity runway would help fund a doubling of indium phosphide manufacturing capacity. That matters because InP wafers are used in high-speed optical interconnects, which is a very fancy way of saying the company wants a bigger seat at the AI infrastructure table.
Big picture
So this is the classic Wall Street tug-of-war: growth story on one side, dilution fear on the other. If management can turn that extra capacity into real demand, today’s selloff might look overdone later. If not? Well, shareholders may keep feeling like they’re being asked to pay for tomorrow with a bigger chunk of their own stock.